PHARMAENGINE, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 93.3 TWD | 0.00% |
|
-1.69% | -11.56% |
| 05-02 | PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 04-24 | PharmaEngine, Inc. Announces First Patient Dosed in Phase I Trial of PEP07 for Solid Tumors | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 101.00 | 101.00 | 118.00 |
| Spread/Res. | -7.62% | -7.62% | -20.93% |
| Spread/Supp. | +6.02% | +6.02% | +11.87% |
| Support | 88.00 | 88.00 | 83.40 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 4162 Stock
- Charts PharmaEngine, Inc.